Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Warrior Met Coal
HCC
$4.19B
| $361K | ﹤0.01% |
10,430
-10,430
| -50% | -$369K |
|
1877
Materion
MTRN
$4.39B
| $361K | ﹤0.01% |
4,129
| – | – |
|
1878
BlueLinx
BXC
$422M
| $361K | ﹤0.01% |
5,080
+39
| +0.8% | +$2.66K |
|
1879
Greif
GEF
$4.92B
| $361K | ﹤0.01% |
5,383
+1,200
| +29% | +$80.9K |
|
|
ROIC
1880
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $361K | ﹤0.01% |
24,016
-24,018
| -50% | -$352K |
|
1881
Carpenter Technology
CRS
$25.8B
| $360K | ﹤0.01% |
9,752
| – | – |
|
1882
Celldex Therapeutics
CLDX
$2.99B
| $360K | ﹤0.01% |
8,084
+1
| +0% | +$36 |
|
1883
Upstart Holdings
UPST
$2.63B
| $360K | ﹤0.01% |
27,266
-16,860
| -38% | -$326K |
|
|
ARNC
1884
DELISTED
Arconic Corporation
ARNC
| $360K | ﹤0.01% |
17,014
-17,016
| -50% | -$356K |
|
1885
Lindsay Corp
LNN
$1.13B
| $359K | ﹤0.01% |
2,208
+1
| +0% | +$165 |
|
1886
Agilysys
AGYS
$2.97B
| $359K | ﹤0.01% |
4,543
| – | – |
|
|
HLTH
1887
DELISTED
Cue Health Inc. Common Stock
HLTH
| $358K | ﹤0.01% |
173,153
-199,087
| -53% | -$629K |
|
1888
Mueller Water Products
MWA
$3.95B
| $358K | ﹤0.01% |
33,263
-14,265
| -30% | -$159K |
|
1889
Krystal Biotech
KRYS
$10.1B
| $358K | ﹤0.01% |
+4,524
| New | +$336K |
|
1890
SAP
SAP
$212B
| $358K | ﹤0.01% |
3,469
+50
| +1% | +$5.01K |
|
1891
TripAdvisor
TRIP
$1.65B
| $357K | ﹤0.01% |
19,845
-19,845
| -50% | -$414K |
|
|
EVA
1892
DELISTED
Enviva Inc.
EVA
| $356K | ﹤0.01% |
6,730
| – | – |
|
1893
Rapid7
RPD
$645M
| $356K | ﹤0.01% |
10,490
-10,490
| -50% | -$375K |
|
|
BLDP
1894
Ballard Power Systems
BLDP
$805M
| $356K | ﹤0.01% |
74,468
-73,532
| -50% | -$417K |
|
1895
Virtu Financial
VIRT
$5.11B
| $356K | ﹤0.01% |
17,437
-9,101
| -34% | -$198K |
|
1896
RLJ Lodging Trust
RLJ
$1.86B
| $355K | ﹤0.01% |
33,511
-33,513
| -50% | -$379K |
|
|
COWN
1897
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $354K | ﹤0.01% |
9,158
-731
| -7% | -$28.2K |
|
1898
Oceaneering
OII
$4.86B
| $353K | ﹤0.01% |
20,166
-20,170
| -50% | -$268K |
|
1899
Viasat
VSAT
$10.6B
| $352K | ﹤0.01% |
11,136
-11,134
| -50% | -$390K |
|
|
KW
1900
DELISTED
Kennedy-Wilson Holdings
KW
| $352K | ﹤0.01% |
22,359
-22,363
| -50% | -$359K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.